www.fdanews.com/articles/73934-tm-to-manufacture-reagents-for-intergenetics
TM TO MANUFACTURE REAGENTS FOR INTERGENETICS
July 1, 2005
Tm Bioscience announced it has signed a five-year agreement to supply custom Tag-It reagents to InterGenetics for OncoVue. According to InterGenetics, OncoVue has been developed as a genetic-based breast cancer risk test relevant to all women. The agreement anticipates InterGenetics will purchase a minimum of $7.5 million in reagents from Tm over the five-year period.
ArriveNet